BECTON, DICKINSON AND COMPANY Lease, Cost
BECTON, DICKINSON AND COMPANY (BDX) reported Lease, Cost of $131.00 million for the 3-month period ending 2020-09-30, per its 10-K filed 2020-11-25.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2020-11-25
- BECTON, DICKINSON AND COMPANY lease, cost for the quarter ending 2020-09-30 was $131.00M.
- BECTON, DICKINSON AND COMPANY lease, cost for the quarter ending 2020-06-30 was $31.00M.
- BECTON, DICKINSON AND COMPANY lease, cost for the quarter ending 2020-03-31 was $32.00M.
- BECTON, DICKINSON AND COMPANY lease, cost for the quarter ending 2019-12-31 was $34.00M.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2020-09-30 | $131.00M 10-K · filed 2020-11-25 | $162.00M derived: sum of 2 quarters · filed 2020-11-25 | $194.00M derived: sum of 3 quarters · filed 2020-11-25 | $228.00M derived: sum of 4 quarters · filed 2020-11-25 |
| 2020-06-30 | $31.00M 10-Q · filed 2020-08-06 | $63.00M derived: sum of 2 quarters · filed 2020-08-06 | $98.00M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $32.00M 10-Q · filed 2020-05-07 | $65.00M 10-Q · filed 2020-05-07 | ||
| 2019-12-31 | $34.00M 10-Q · filed 2020-02-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |